skip to content
National Cancer Institute, cancer.gov

Funding by Cancer Type

Funding by Cancer Type provides estimated funding levels for frequently requested areas of cancer research. These areas do not represent the full range of research funded by the NCI.

Fiscal Year: 

Breakdown — 2011

($ in Thousands)
Disease AreaFunding% of NCI Budget
AIDS
$269,9535.3 %
Brain & Central Nervous System
$172,5823.4 %
Breast Cancer
$625,06012.4 %
Cervical Cancer
$81,3791.6 %
Clinical Trials
$877,78217.4 %
Colorectal Cancer
$265,1255.2 %
Head and Neck Cancers
$58,1651.1 %
Hodgkin Disease
$13,3790.3 %
Leukemia
$227,0254.5 %
Liver Cancer
$66,1811.3 %
Lung Cancer
$296,8145.9 %
Melanoma
$115,6402.3 %
Multiple Myeloma
$54,9171.1 %
Non-Hodgkin Lymphoma
$126,3762.5 %
Ovarian Cancer
$110,8252.2 %
Pancreatic Cancer
$99,4592.0 %
Prostate Cancer
$288,3275.7 %
Stomach Cancer
$13,3780.3 %
Uterine Cancer
$15,8700.3 %
The data presented on this page represent funding levels for frequently requested areas of cancer research and do not represent the entire NCI research portfolio. A research project may be counted in multiple categories (for example, funding for a clinical trial on breast cancer research is included in the totals for both the Breast Cancer and Clinical Trials categories), thus the sum of the cancer research areas does not add up to the total NCI budget.
National Cancer Institute U.S. National Institutes of Health www.cancer.gov National Cancer Institute National Institutes of Health U.S. Department of Health & Human Services USA.gov